In Brief This Week: PerkinElmer; DaVita, Roche; Unilabs, BGI; Intrexon; Agilent; Danaher; Sigma-Aldrich; GE Healthcare | GenomeWeb

NEW YORK (GenomeWeb News) – PerkinElmer reduced its headcount by 17 in the first quarter as part of a restructuring plan, it said in its Form 10-Q this week. The company recognized pre-tax restructuring charges of $400,000 and $200,000 in its Human Health segment and Environmental Health segment, respectively, as a result. PerkinElmer also shut down its Signature Genomics business subsequent to the end of the first quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: Neanderthal-derived DNA linked to modern ailments, and more.

Japan needs to catch up on its gene-editing research efforts, the Japan News writes.

Hundreds of people have signed an online petition calling for zero tolerance to sexual harassment in the sciences.

Jeff Huber, former Google X senior vice president, joins Grail as its CEO.